Skip to main content
. 2010 Mar 24;285(21):16360–16368. doi: 10.1074/jbc.M110.100669

TABLE 2.

Oligonucleotides used in this study

Oligonucleotide/use Sequence 5′-3′ (restriction sites are underlined)
Construction of pIZ1708
    dnaj5′ ATGCGAATTCATGGCTCCGCAGAACCTGAG
    dnaj3′ TGACCTCGAGGTCCAATTTTATTCACTCTC

Construction of pIZ1729
    3HA5′ ATCGCTCGAGTACCCATACGATGTTCC
    3HA3′ TGCATCTAGATCAGCCAGCGTAGTCTGGTAC
    Dnajbam5′ CTGAGGATCCACCATGGCTCCGCAGAACCTGAG
    Dnajxho3′ TGACCTCGAGATATCCTTGCAGTCCATTGTATAC

Construction of pIZ1791 and pIZ1797
    dnaj23eco5′ CATGGAATTCGGACGAGATTTCTATAAGATC
    dnaj3′ as above

Construction of pIZ1792 and pIZ1798
    dnaj88eco5′ CATGGAATTCACTTATGGTGAAGAAGGATTAAAAG
    dnaj3′ as above

Construction of pIZ1793 and pIZ1799
    dnaj129eco5′ CATGGAATTCCCAAGAGGAAGTGATATTATTG
    dnaj3′ as above

Construction of pIZ1794 and pIZ1800
    dnaj160eco5′ GATCGAATTCGCAAGGCAGGCTCCTGGCAAAC
    dnaj3′ as above

Construction of pIZ1795 and pIZ1801
    dnaj201eco5′ CATGGAATTCCTAGTGAATGAAGAACGAAC
    dnaj3′ as above

Construction of pIZ1796 and pIZ1802
    dnaj251eco5′ CATGGAATTCTTTGAAAGGAGAGGAGATGATTTG
    dnaj3′ as above

Sequencing of pGADT7 derivatives
    T7 TAATACGACTCACTATAGGG

Sequencing of pGEX derivatives
    pgex5′ GGGCTGGCAAGCCACGTTTGGTG
    pgex3′ CCGGGAGCTGCATGTGTCAGAGG